Pulmonary alveolar proteinosis - A rare pulmonary toxicity of sirolimus

Transplant International

Volumn 20, Issue 3, 2007, Pages 291-296

  Pedroso, Sofia L ^a   Martins, La Salete ^a   Sousa, Sónia ^a   Reis, Abílio ^a   Dias, Leonídio ^a   Henriques, António C ^a   Sarmento, António M ^a   Cabrita, António ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Immunosuppression; Kidney transplant; Pulmonary alveolar proteinosis; Rapamycin; Sirolimus

Indexed keywords

ATENOLOL; CYCLOSPORIN A; FUROSEMIDE; LACTATE DEHYDROGENASE; LOSARTAN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; SIMVASTATIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALOPECIA; ARTICLE; BRONCHOSCOPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSPNEA; FEMALE; FEVER; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; LUNG TOXICITY; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; THORAX PAIN;

ADULT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; PULMONARY ALVEOLAR PROTEINOSIS; SIROLIMUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33846983915     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00408.x     Document Type: Article

References (18)

1. Kahan BD, Julian BA, Pescovitz MD, Vanrenterghem Y, Neylan J. Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: a phase II trial. Transplantation 1999; 68: 1526.
2. Groth CG, Backman L, Morales JM, et al. Sirolimus (Rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Transplantation 1999; 67: 1036.
3. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet 1999; 353: 1083.
4. Chueh S-CJ, Kahan BD. Clinical application of sirolimus in renal transplantation: an update. Transpl Int 2005; 18: 261.
5. Morelon E, Mamzer-Bruneel M-F, Peraldi M-N, Kreis H. Sirolimus: a new promising immunosuppressive drug. Towards a rationale for its use in renal transplantation. Nephrol Dial Transplant 2001; 16: 18.
6. Lennon A, Finan K, FitzGerald MX, et al. Interstitial pneumonitis associated with sirolimus (Rapamycin) therapy after liver transplantation. Transplantation 2000; 72: 1166.
7. Singer SJ, Tiernan R, Sullivan EJ. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000; 343: 225.
8. Morelon E, Stern M, Kreis H. Interstitial pneumonitis associated with sirolimus therapy in renal-transplant recipients. N Engl J Med 2000; 343: 1815.
9. Garrean S, Massad MG, Tshibaka M, Hanhan Z, Caines AE, Benedetti E. Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients. Clin Transplant 2005; 19: 698.
10. Seethamraju H, Kaleekak TS, Bag R. Pulmonary toxicity of sirolimus in lung transplant patients. Chest 2003; 124: 101S (Abstract).
11. Chau EMC, Chow W-H. Sirolimus-induced pneumonitis presenting as acute respiratory distress syndrome. J Heart Lung Transplant 2006; 25: 867.
12. Hamour IM, Mittal TK, Bell AD, Banner NR. Reversible sirolimus-associated pneumonitis after heart transplantation. J Heart Lung Transplant 2006; 25: 241.
13. Morelon E, Stern M, Israel-Biet D, et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients. Transplantation 2001; 72: 787.
14. Champion L, Stern M, Israel-Biet D, et al. Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients. Ann Intern Med 2006; 144: I45.
15. Trapnell BC, Whitsett JA, Nakata K. Mechanism of disease: pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527.
16. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215.
17. Cordonnier C, Fleury-Feith J, Escudier E, Atassi K, Bernaudin JF. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994; 149: 788.
18. Wardwell NR Jr, Miller R, Ware LB. Pulmonary alveolar proteinosis associated with a disease-modifying antirheumatoid arthritis drug. Respirology 2006; 11: 663.